A citation-based method for searching scientific literature

Clinton Yam, Brigette B Y Ma, Timothy A Yap. JCO Precis Oncol 2021
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
F Mosele, J Remon, J Mateo, C B Westphalen, F Barlesi, M P Lolkema, N Normanno, A Scarpa, M Robson, F Meric-Bernstam,[...]. Ann Oncol 2020
289
100

Development and Evaluation of a Pan-Sarcoma Fusion Gene Detection Assay Using the NanoString nCounter Platform.
Kenneth T E Chang, Angela Goytain, Tracy Tucker, Aly Karsan, Cheng-Han Lee, Torsten O Nielsen, Tony L Ng. J Mol Diagn 2018
41
50

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant,[...]. J Clin Oncol 2006
50

2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary.
F Losa, L Iglesias, M Pané, J Sanz, B Nieto, V Fusté, L de la Cruz-Merino, Á Concha, C Balañá, X Matías-Guiu. Clin Transl Oncol 2018
15
50

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
J Remon, R García-Campelo, E de Álava, R Vera, J L Rodríguez-Peralto, Á Rodríguez-Lescure, B Bellosillo, P Garrido, F Rojo, R Álvarez-Alegret. Clin Transl Oncol 2020
18
50

GREM1 and POLE variants in hereditary colorectal cancer syndromes.
Anna Rohlin, Frida Eiengård, Ulf Lundstam, Theofanis Zagoras, Staffan Nilsson, Anders Edsjö, Jan Pedersen, Janhenry Svensson, Stefan Skullman, B Göran Karlsson,[...]. Genes Chromosomes Cancer 2016
31
50

Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
Lídia Feliubadaló, Adrià López-Fernández, Marta Pineda, Orland Díez, Jesús Del Valle, Sara Gutiérrez-Enríquez, Alex Teulé, Sara González, Neda Stjepanovic, Mónica Salinas,[...]. Int J Cancer 2019
21
50

Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain.
A Rodríguez-Lescure, F A de la Peña, E Aranda, A Calvo, E Felip, P Garrido, R Vera. Clin Transl Oncol 2020
3
50

MicroRNAs accurately identify cancer tissue origin.
Nitzan Rosenfeld, Ranit Aharonov, Eti Meiri, Shai Rosenwald, Yael Spector, Merav Zepeniuk, Hila Benjamin, Norberto Shabes, Sarit Tabak, Asaf Levy,[...]. Nat Biotechnol 2008
717
50

Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
Jasleen K Grewal, Basile Tessier-Cloutier, Martin Jones, Sitanshu Gakkhar, Yussanne Ma, Richard Moore, Andrew J Mungall, Yongjun Zhao, Michael D Taylor, Karen Gelmon,[...]. JAMA Netw Open 2019
31
50

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Robert C Doebele, Alexander Drilon, Luis Paz-Ares, Salvatore Siena, Alice T Shaw, Anna F Farago, Collin M Blakely, Takashi Seto, Byung Chul Cho, Diego Tosi,[...]. Lancet Oncol 2020
535
50

Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Spring Holter, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, Steven Narod, Mohammad Akbari, Malcolm Moore,[...]. J Clin Oncol 2015
240
50

Genomic profiling in oncology clinical practice.
N Rodríguez, D Viñal, J Rodríguez-Cobos, J De Castro, G Domínguez. Clin Transl Oncol 2020
3
50

Liquid biopsy enters the clinic - implementation issues and future challenges.
Michail Ignatiadis, George W Sledge, Stefanie S Jeffrey. Nat Rev Clin Oncol 2021
250
50

Gene panel testing for inherited cancer risk.
Michael J Hall, Andrea D Forman, Robert Pilarski, Georgia Wiesner, Veda N Giri. J Natl Compr Canc Netw 2014
86
50

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
Fatima Cardoso, Laura J van't Veer, Jan Bogaerts, Leen Slaets, Giuseppe Viale, Suzette Delaloge, Jean-Yves Pierga, Etienne Brain, Sylvain Causeret, Mauro DeLorenzi,[...]. N Engl J Med 2016
955
50

Implementing Precision Medicine in Community-Based Oncology Programs: Three Models.
Laura A Levit, Edward S Kim, Barbara L McAneny, Lincoln D Nadauld, Kathryn Levit, Caroline Schenkel, Richard L Schilsky. J Oncol Pract 2019
33
50



Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Piper Nicolosi, Elisa Ledet, Shan Yang, Scott Michalski, Brandy Freschi, Erin O'Leary, Edward D Esplin, Robert L Nussbaum, Oliver Sartor. JAMA Oncol 2019
153
50

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.
Claire Palles, Jean-Baptiste Cazier, Kimberley M Howarth, Enric Domingo, Angela M Jones, Peter Broderick, Zoe Kemp, Sarah L Spain, Estrella Guarino, Israel Salguero,[...]. Nat Genet 2013
642
50

A profile on the FoundationFocus CDxBRCA tests.
Lindsey Ford, Juliet E Wolford, Sandra M Brown, Leslie M Randall. Expert Rev Mol Diagn 2020
10
50

Screening for germline mutations in mismatch repair genes in patients with Lynch syndrome by next generation sequencing.
Barbara Luísa Soares, Ayslan Castro Brant, Renan Gomes, Tatiane Pastor, Naye Balzan Schneider, Ândrea Ribeiro-Dos-Santos, Paulo Pimentel de Assumpção, Maria Isabel W Achatz, Patrícia Ashton-Prolla, Miguel Angelo Martins Moreira. Fam Cancer 2018
12
50

PARP inhibitors in the treatment of ovarian cancer: a review.
Christina R Washington, Kathleen N Moore. Curr Opin Obstet Gynecol 2021
6
50

ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
C Marchiò, M Scaltriti, M Ladanyi, A J Iafrate, F Bibeau, M Dietel, J F Hechtman, T Troiani, F López-Rios, J-Y Douillard,[...]. Ann Oncol 2019
163
50

Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
N Stjepanovic, L Moreira, F Carneiro, F Balaguer, A Cervantes, J Balmaña, E Martinelli. Ann Oncol 2019
66
50

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
Chunling Hu, Steven N Hart, Eric C Polley, Rohan Gnanaolivu, Hermela Shimelis, Kun Y Lee, Jenna Lilyquist, Jie Na, Raymond Moore, Samuel O Antwi,[...]. JAMA 2018
260
50

A second-generation microRNA-based assay for diagnosing tumor tissue origin.
Eti Meiri, Wolf C Mueller, Shai Rosenwald, Merav Zepeniuk, Elizabeth Klinke, Tina Bocker Edmonston, Margot Werner, Ulrike Lass, Iris Barshack, Meora Feinmesser,[...]. Oncologist 2012
103
50

Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
P García-Alfonso, R García-Carbonero, J García-Foncillas, P Pérez-Segura, R Salazar, R Vera, S Ramón Y Cajal, J Hernández-Losa, S Landolfi, E Musulén,[...]. Clin Transl Oncol 2020
6
50

Precision Medicine: An Emerging Paradigm for Improved Diagnosis and Safe Therapy in Pediatric Oncology.
Puneet Singla, Pankaj Musyuni, Geeta Aggarwal, Harjinder Singh. Cureus 2021
2
50

Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer.
Heather H Cheng, Colin C Pritchard, Thomas Boyd, Peter S Nelson, Bruce Montgomery. Eur Urol 2016
190
50

BRACAnalysis CDx as a companion diagnostic tool for Lynparza.
Camille C Gunderson, Kathleen N Moore. Expert Rev Mol Diagn 2015
26
50

Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma.
Chiara Nicolazzo, Luciano Colangelo, Alessandro Corsi, Guido Carpino, Angela Gradilone, Chiara Sonato, Cristina Raimondi, Eugenio Gaudio, Paola Gazzaniga, Walter Gianni. Anal Cell Pathol (Amst) 2018
9
50

CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Yue Zhao, Ziwei Pan, Sandeep Namburi, Andrew Pattison, Atara Posner, Shiva Balachander, Carolyn A Paisie, Honey V Reddi, Jens Rueter, Anthony J Gill,[...]. EBioMedicine 2020
19
50

Identification of germline genetic mutations in patients with pancreatic cancer.
Erin E Salo-Mullen, Eileen M O'Reilly, David P Kelsen, Asad M Ashraf, Maeve A Lowery, Kenneth H Yu, Diane L Reidy, Andrew S Epstein, Anne Lincoln, Amethyst Saldia,[...]. Cancer 2015
128
50

Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care.
Alexander Penson, Niedzica Camacho, Youyun Zheng, Anna M Varghese, Hikmat Al-Ahmadie, Pedram Razavi, Sarat Chandarlapaty, Christina E Vallejo, Efsevia Vakiani, Teresa Gilewski,[...]. JAMA Oncol 2020
33
50

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.
Sebastian Moran, Anna Martínez-Cardús, Sergi Sayols, Eva Musulén, Carme Balañá, Anna Estival-Gonzalez, Cátia Moutinho, Holger Heyn, Angel Diaz-Lagares, Manuel Castro de Moura,[...]. Lancet Oncol 2016
241
50

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
J Mateo, D Chakravarty, R Dienstmann, S Jezdic, A Gonzalez-Perez, N Lopez-Bigas, C K Y Ng, P L Bedard, G Tortora, J-Y Douillard,[...]. Ann Oncol 2018
215
50

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
Richard G Gray, Philip Quirke, Kelly Handley, Margarita Lopatin, Laura Magill, Frederick L Baehner, Claire Beaumont, Kim M Clark-Langone, Carl N Yoshizawa, Mark Lee,[...]. J Clin Oncol 2011
254
50


Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier.
Sarah E Kerr, Catherine A Schnabel, Peggy S Sullivan, Yi Zhang, Veena Singh, Brittany Carey, Mark G Erlander, W Edward Highsmith, Sarah M Dry, Elena F Brachtel. Clin Cancer Res 2012
57
50

Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.
P Garrido, A Aldaz, R Vera, M A Calleja, E de Álava, M Martín, X Matías-Guiu, J Palacios. Clin Transl Oncol 2018
13
50

Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification.
Mark G Erlander, Xiao-Jun Ma, Nicole C Kesty, Lei Bao, Ranelle Salunga, Catherine A Schnabel. J Mol Diagn 2011
62
50

Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary.
Sebastián Moran, Anna Martinez-Cardús, Stergios Boussios, Manel Esteller. Nat Rev Clin Oncol 2017
53
50

Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
Robert C Grant, Iris Selander, Ashton A Connor, Shamini Selvarajah, Ayelet Borgida, Laurent Briollais, Gloria M Petersen, Jordan Lerner-Ellis, Spring Holter, Steven Gallinger. Gastroenterology 2015
197
50

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
David S Hong, Steven G DuBois, Shivaani Kummar, Anna F Farago, Catherine M Albert, Kristoffer S Rohrberg, Cornelis M van Tilburg, Ramamoorthy Nagasubramanian, Jordan D Berlin, Noah Federman,[...]. Lancet Oncol 2020
336
50

Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
R Colomer, I Aranda-López, J Albanell, T García-Caballero, E Ciruelos, M Á López-García, J Cortés, F Rojo, M Martín, J Palacios-Calvo. Clin Transl Oncol 2018
41
50

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
50

Development and validation of a gene expression tumour classifier for cancer of unknown primary.
Richard W Tothill, Fan Shi, Lisa Paiman, Justin Bedo, Adam Kowalczyk, Linda Mileshkin, Evangeline Buela, Robert Klupacs, David Bowtell, Keith Byron. Pathology 2015
25
50

Familial pancreatic cancer.
Gloria M Petersen. Semin Oncol 2016
76
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.